List of Tables
Table 1. Global Lysosomal Storage Disease Treatment Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Lysosomal Storage Disease Treatment Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Lysosomal Storage Disease Treatment Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Lysosomal Storage Disease Treatment Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Lysosomal Storage Disease Treatment Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Lysosomal Storage Disease Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Lysosomal Storage Disease Treatment Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Lysosomal Storage Disease Treatment Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Lysosomal Storage Disease Treatment Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Lysosomal Storage Disease Treatment Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lysosomal Storage Disease Treatment Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lysosomal Storage Disease Treatment Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lysosomal Storage Disease Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Lysosomal Storage Disease Treatment Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Lysosomal Storage Disease Treatment Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Lysosomal Storage Disease Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Lysosomal Storage Disease Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Lysosomal Storage Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Lysosomal Storage Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Lysosomal Storage Disease Treatment Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Lysosomal Storage Disease Treatment Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Lysosomal Storage Disease Treatment Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Lysosomal Storage Disease Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Lysosomal Storage Disease Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Lysosomal Storage Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Lysosomal Storage Disease Treatment Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Lysosomal Storage Disease Treatment Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Lysosomal Storage Disease Treatment Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Lysosomal Storage Disease Treatment Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Lysosomal Storage Disease Treatment Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Sanofi Lysosomal Storage Disease Treatment Drugs Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Takeda Company Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Takeda Lysosomal Storage Disease Treatment Drugs Product
Table 79. Takeda Recent Developments/Updates
Table 80. BioMarin Company Information
Table 81. BioMarin Description and Business Overview
Table 82. BioMarin Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. BioMarin Lysosomal Storage Disease Treatment Drugs Product
Table 84. BioMarin Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. AbbVie Lysosomal Storage Disease Treatment Drugs Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Alexion Company Information
Table 91. Alexion Description and Business Overview
Table 92. Alexion Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Alexion Lysosomal Storage Disease Treatment Drugs Product
Table 94. Alexion Recent Developments/Updates
Table 95. Allergan Company Information
Table 96. Allergan Description and Business Overview
Table 97. Allergan Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Allergan Lysosomal Storage Disease Treatment Drugs Product
Table 99. Allergan Recent Developments/Updates
Table 100. Horizon Pharma Company Information
Table 101. Horizon Pharma Description and Business Overview
Table 102. Horizon Pharma Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Horizon Pharma Lysosomal Storage Disease Treatment Drugs Product
Table 104. Horizon Pharma Recent Developments/Updates
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Johnson & Johnson Lysosomal Storage Disease Treatment Drugs Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Actelion Company Information
Table 111. Actelion Description and Business Overview
Table 112. Actelion Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Actelion Lysosomal Storage Disease Treatment Drugs Product
Table 114. Actelion Recent Developments/Updates
Table 115. Recordati Rare Diseases Company Information
Table 116. Recordati Rare Diseases Description and Business Overview
Table 117. Recordati Rare Diseases Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Recordati Rare Diseases Lysosomal Storage Disease Treatment Drugs Product
Table 119. Recordati Rare Diseases Recent Developments/Updates
Table 120. Pfizer Company Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Pfizer Lysosomal Storage Disease Treatment Drugs Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Digestive Care Company Information
Table 126. Digestive Care Description and Business Overview
Table 127. Digestive Care Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Digestive Care Lysosomal Storage Disease Treatment Drugs Product
Table 129. Digestive Care Recent Developments/Updates
Table 130. Leadiant Biosciences Company Information
Table 131. Leadiant Biosciences Description and Business Overview
Table 132. Leadiant Biosciences Lysosomal Storage Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Leadiant Biosciences Lysosomal Storage Disease Treatment Drugs Product
Table 134. Leadiant Biosciences Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Lysosomal Storage Disease Treatment Drugs Distributors List
Table 138. Lysosomal Storage Disease Treatment Drugs Customers List
Table 139. Lysosomal Storage Disease Treatment Drugs Market Trends
Table 140. Lysosomal Storage Disease Treatment Drugs Market Drivers
Table 141. Lysosomal Storage Disease Treatment Drugs Market Challenges
Table 142. Lysosomal Storage Disease Treatment Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lysosomal Storage Disease Treatment Drugs
Figure 2. Global Lysosomal Storage Disease Treatment Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Lysosomal Storage Disease Treatment Drugs Market Share by Type: 2025 & 2032
Figure 4. Oral Treatment Product Picture
Figure 5. Injection Treatment Product Picture
Figure 6. Global Lysosomal Storage Disease Treatment Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Lysosomal Storage Disease Treatment Drugs Market Share by Application: 2025 & 2032
Figure 8. Fabry Disease
Figure 9. Gaucher Disease
Figure 10. Pompe Disease
Figure 11. Other
Figure 12. Global Lysosomal Storage Disease Treatment Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Lysosomal Storage Disease Treatment Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Lysosomal Storage Disease Treatment Drugs Sales (K Units), 2021–2032
Figure 15. Global Lysosomal Storage Disease Treatment Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Lysosomal Storage Disease Treatment Drugs Report Years Considered
Figure 17. Lysosomal Storage Disease Treatment Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Lysosomal Storage Disease Treatment Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Lysosomal Storage Disease Treatment Drugs Players: Market Share by Revenue in Lysosomal Storage Disease Treatment Drugs in 2025
Figure 20. Lysosomal Storage Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Lysosomal Storage Disease Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Lysosomal Storage Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Lysosomal Storage Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Lysosomal Storage Disease Treatment Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Lysosomal Storage Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Lysosomal Storage Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Lysosomal Storage Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Lysosomal Storage Disease Treatment Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Lysosomal Storage Disease Treatment Drugs by Type (2021–2032)
Figure 55. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Lysosomal Storage Disease Treatment Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Lysosomal Storage Disease Treatment Drugs by Application (2021–2032)
Figure 58. Global Lysosomal Storage Disease Treatment Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Lysosomal Storage Disease Treatment Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
